SOURCE-LINKED STUDY SUMMARY
Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.
What was studied?
A randomized placebo-controlled study tested androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.
What changed?
The trial evaluated whether androgen exposure could counter glucocorticoid-associated changes in muscle mass, strength and bone density, alongside quality-of-life outcomes.
Who was studied?
Men receiving chronic glucocorticoids were studied for changes in muscle, bone and related clinical outcomes.
Studied exposure
Participants were assigned to an androgen treatment or placebo during ongoing glucocorticoid therapy; the accessible abstract reports the controlled comparison.
What remains uncertain?
The study addressed a glucocorticoid-treated clinical population and cannot be used to infer the effects or safety of anabolic treatment in healthy athletes.
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1210/jc.2002-021827